OPRK1 and respiratory depression: We have previously shown that the multifunctional macrocyclic tetrapeptide cyclo[Pro-Sar-Phe-d-Phe] exhibits reduced liabilities, particularly respiratory effects, and that the peptide’s KOR agonist activity appears to offset respiratory depression mediated by MOR [9].